Results 281 to 287 of about 124,093 (287)

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

Neuropharmacology, 1983
H Wachtel
exaly  

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John K Walker, Michael J Palmer, Brian R Bond   +2 more
exaly  

The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review

Journal of Cerebral Blood Flow and Metabolism, 2018
Mathilde Pauls, Barry Moynihan, Thomas R Barrick   +2 more
exaly  

6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure–activity relationship

Bioorganic and Medicinal Chemistry, 2012
Zarbad Shāh, Muhammad Taha, Fazal Rahim   +2 more
exaly  

A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases

Biomedicine and Pharmacotherapy, 2017
Reza Shafiee-Nick, Amir R Afshari, Seyed Hadi Mousavi   +2 more
exaly  

Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium

Naunyn-Schmiedeberg's Archives of Pharmacology, 1999
Marc Bardou, J Cortijo, Catherine Deneux-Tharaux   +2 more
exaly  

1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John K Walker, Michael J Palmer, Brian R Bond   +2 more
exaly